July 2026
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effectiveness of the Health Storylines mAPP for self-management among individuals with chronic illnesses in Baguio City, Philippines, finding no significant differences in self-management scores.
Interventions
Health Storylines mAPPTraditional pamphlet
Outcomes
Diabetes self-management behaviorsPost-test self-management score
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effects of oral multivitamins and multiminerals (OMVM) in patients with diabetes and a history of myocardial infarction. The findings indicated no significant differences in major cardiovascular outcomes between the OMVM and placebo groups.
Interventions
Oral multivitamins and multiminerals (OMVM)
Outcomes
Adverse events incidenceAll-cause mortalityComposite of CV death, non-fatal myocardial infarction, or non-fatal stroke+4 more
Added to Dediabetes Jul 12, 2026RCTs
This study compared high-dose and standard-dose influenza vaccines in older adults with diabetes, finding that HD-IIV reduced hospitalizations for various diseases.
Interventions
High-dose inactivated influenza vaccine (HD-IIV)Standard-dose inactivated influenza vaccine (SD-IIV)
Outcomes
Hospitalization for any cardiorespiratory diseaseHospitalization for any cardiovascular diseaseHospitalization for influenza
Added to Dediabetes Jul 12, 2026Non Randomized CT
This case report examined the effects of high-dose vitamin D therapy on partial clinical remission in a participant with Type 1 Diabetes.
Interventions
Vitamin D supplementation
Outcomes
HbA1cInsulin-dose adjusted A1c (IDAA1c)Serum 25-hydroxyvitamin D+2 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the impact of high-dose Vitamin D3 supplementation on insulin resistance and glycaemic parameters in adult males with type 2 diabetes, finding no significant differences in most outcomes.
Interventions
Vitamin D supplementation
Outcomes
BMIFasting Plasma Glucose (FPG)Fasting insulin levels+4 more
Added to Dediabetes Jul 12, 2026RCTs
The AWARD-11 trial compared the effects of Dulaglutide 3.0 mg and 4.5 mg to 1.5 mg on body weight in patients with type 2 diabetes, finding significant weight reductions.
Interventions
DulaglutideDulaglutiden dose
Outcomes
Activities of daily livingBMIHbA1c+1 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effects of higher doses of semaglutide on glucose levels in type 2 diabetes patients, finding modest additional benefits at higher doses.
Outcomes
Adverse events incidenceBody weightC-reactive protein+6 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the efficacy and safety of HRS-7535 in adults with type 2 diabetes inadequately controlled with metformin, showing significant reductions in HbA1c and fasting plasma glucose levels.
Interventions
HRS-7535 (15 mg)HRS-7535 (30 mg)HRS-7535 (60 mg)+1 more
Outcomes
Fasting Plasma Glucose (FPG)HbA1c
Added to Dediabetes Jul 12, 2026RCTs
This study examined the impact of hybrid closed-loop insulin therapy on insulin delivery patterns in youth with type 1 diabetes, finding a significant decrease in bolus insulin use.
Interventions
Insulin therapy
Outcomes
Glucose iAUC (OGTT)Insulin delivered per 10 g of carbohydrateMean daily carbohydrate-related bolus insulin+3 more
Added to Dediabetes Jul 12, 2026RCTs
This study compared diabetes-specific psychological outcomes in adults with type 1 diabetes using hybrid closed-loop therapy versus standard therapy, finding that the hybrid approach led to improved well-being and reduced distress.
Interventions
Hybrid closed-loop systemInsulin pump or multiple daily injections
Outcomes
Diabetes distress scoresFear of hypoglycemia (worry)Hypoglycemia symptom score+6 more